Synthesis and biological evaluation of new pentaphyrin macrocycles for photodynamic therapy

Journal of Medicinal Chemistry

Volumn 49, Issue 1, 2006, Pages 196-204

  Comuzzi, Clara ^a   Cogoi, Susanna ^b   Overhand, Mark ^c   Van Der Marel, Gijs A ^c   Overkleeft, Herman S ^c   Xodo, Luigi E ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIFORMYL 5 PHENYLDIPYRROMETHANE; CYTOTOXIC AGENT; ISOPENTAPHYRIN; MACROCYCLIC COMPOUND; PENTAPHYRIN; PENTAPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TRIPYRRANE DICARBOXYLIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOPLASM; DOSE RESPONSE; DRUG SYNTHESIS; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME ASSAY; EVALUATION RESEARCH; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PRODUCT RECOVERY;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIGHT; MACROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; PHOTOSENSITIZING AGENTS; PORPHYRINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 30444461518     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050831l     Document Type: Article

References (42)

1. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
2. Sibata, C. H.; Colussi, V. C.; Oleinick, N. L.; Kinsella, T. J. Photodynamic therapy in oncology. Expert. Opin. Pharmacother. 2001, 2, 917-927.
3. Dougherty, T. J. An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 2002, 20, 3-7.
4. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90, 889-905.
5. Miller, J. Photodynamic Therapy: the sensitization of cancer cells to light. Chem. Educ. Today 1999, 76, 592-594.
6. Pervaiz, S. Reactive oxygen-dependent production of novel photochemotherapeutic agents. FASEB J. 2001, 15, 612-617.
7. Moan, J.; Berg, K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 1991, 53, 549-53.
8. Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X.-H.; Childs, C. J. H.; Sibata, C. H. Photosensitizes in clinical PDT. Photodiagn. Photodyn. Ther. 2004, 1, 27-42.
9. Bonnett, R.; Berembaum, M. C. HpD-a study of its components and their properties. Adv. Exp. Med. Biol. 1983, 160, 241-250.
10. Dogherty, T. J. A brief story of clinical photodynamic therapy development at Roswell Park Cancer Institute. J. Clin. Laser Med. 1996, 14, 219-221.
11. Stenberg, E. D.; Dolphin, D.; Bruckner, C. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 1998, 54, 4191-4202.
12. Dolphin, D. Photomedicine and Photodynamic Therapy. Can. J. Chem. 1994, 72, 1005-1013.
13. Sibata, C. H.; Colussi, V. C.; Oleinick, N. L.; Kinsella, T. J. Photodynamic therapy in oncology. Exp. Opin. Pharmacother. 2001, 2, 917-927.
14. Sessler, J. L.; Seidel, D. Synthetic Expanded Porphyrin Chemistry. Angew. Chem. Int. Ed. 2003, 42, 5134-5175.
15. Jasat, A.; Dolphin, D. Expanded Porphyrins and Their Heterologs. Chem. Rev. 1997, 97, 2267-2340.
16. Lang, K.; Monsinger, J.; Wagnerova, D. M. Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapy. Coord. Chem. Rev. 2004, 248, 321-350.
17. Shin, Ji.-Y.; Furuta, H.; Osuka, A. N-Fused Pentaphyrin. Angew. Chem., Int. Ed. 2001, 40, 619-621.
18. Srinivasan, A.; Ishizuka, T.; Furuta, H. Doubly N-fused Pentaphyrins. Angew. Chem., Int. Ed. 2004, 43, 876-879.
19. Khoury, R. G.; Jaquinod, L.; Nguyen, L. T.; Smith, K. M. Macrocycles containing five pyrrole subunits: the Iso-oxopentaphyrin System. Heterocycles 1998, 47, 113-119.
20. Danso-Danquah, R. E.; Xie, L. Y.; Dolphin, D. Characterization of Decamethyl and Ethoxycarbonyl Pentaphyrins. Heterocycles 1995, 41, 2553-2564.
21. Krivokapic, A.; Cowley, A. R.; Anderson, H. L. Contracted and Expanded meso-Alkynyl Porphyrinoids: from Triphyrin to Hexaphyrin. J. Org. Chem. 2003, 68, 1089-1096.
22. Rexhausen, H.; Gossauer, A. The Synthesis of a New 22 π-Electron Macrocycle: Pentaphyrin. J. Chem. Soc., Chem. Commun. 1983, 275.
23. Lin, Y.; Lash, T. D. Porphyrin synthesis by the "3+1" methodology: a superior approach for the preparation of porphyrins with fused 9,10-phenantroline subunits. Tetrahedron Lett. 1995, 36, 9441-9444.
24. Lash, T. D. Porphyrins with exocyclic rings. Part 9 [1] synthesis of porphyrins by the "3+1" approach. J. Porphyrins Phthalocyanins 1997, 1, 29-44.
25. Sessler, J. L.; Johnson, M. R.; Linch, V. Synthesis and crystal structures of a novel tripyrrane-containing porphyrogen-like macrocycle. J. Org. Chem. 1987, 52, 4394-4397.
26. Clarke, O. J.; Boyle, R. W. Selective synthesis of asymmetrically substituted 5,15- diphenylporphyrins. Tetrahedron Lett. 1998, 39, 7167-7168.
27. Bruckner, C.; Posakony, J. F.; Johnson, C. K.; Boyle, R. W.; James, B. R.; Dolphin, D. Novel and Improved Syntheses of 5,15-Diphenylporphyrin and its Dipyrrolic Precursors. J. Porphyrins Phthalocyanines 1998, 2, 455-465.
28. Brinas, R. P.; Bruckner C. Synthesis of 5,10-diphenylporphyrin. Tetrahedron 2002, 58, 4375-4381.
29. Littler, B. J.; Miller, M. A.; Hung, C.; Wagner, R. W.; O'Shea, D. F.; Boyle, P. D.; Lindsey, J. S. Refined Synthesis of 5-Substituted Dipyrromethanes. J. Org. Chem. 1999, 64, 1391-1396.
30. Kral, V.; Brucker, E. A.; Hemmi, G.; Sessler, J. L.; Kralova, J.; Bose, H., Jr. A non-ionic water-soluble pentaphyrin derivatives. Synthesis and cytotoxicity. Bioorg. Med. Chem. 1995, 3, 573-578.
31. Fhurhop, J. H.; Demoulin, C.; Boettcher, C.; Koning, J.; Siggel, U. Chiral micellar porhyrin fibers with 2-aminoglycosamide head-groups. J. Am. Chem. Soc. 1992, 114, 4159.
32. Haughland, R. P. Handbook of fluorescent probes and research chemicals. In Spence, M. T. Z., Ed.; Nucleic Acids Detection: Molecular Probes: Eugene, OR; pp 143-168.
33. Moan, J.; Berg, K. Porphyrin photosensitization and phototherapy. Photochem. Photobiol. 1986, 43, 681-690.
34. Guzburg, W. H.; Salmons, B. Novel clinical strategies for the treatment of pancreatic carcinoma. Trends Mol. Med. 2001, 7, 30-37.
35. Sylvain, I.; Zerrouki, R.; Granet, R.; Huang, Y. M.; Lagorce, J.-F.; Guilloton, M.; Blais, J.-C.; Krausz, P. Synthesis and biological evaluation of thioglycosylated porphyrins for an application in photodynamic therapy. Bioorg. Med. Chem. 2002, 10, 57-69.
36. Agarwal, M. L.; Clay, M. E.; Harvey, E. J.; Evans, H. H.; Antunez, A. R.; Oleinick, N. L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 1991, 51, 5993-5996.
37. Vaux, D. L.; Strasser, A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 2239-2244.
38. Hickman, J. A.; Potten, C. S.; Meritt, A. J.; Fisher, T. C. Apoptosis and cancer chemiotherapy. Philos. Trans R Soc. London B Biol. Sci. 1994, 345, 319-325.
39. Darzynkiewicz, Z.; Bruno, S.; Del Bino, S.; Gorzyca, W.; Hotz, M. A.; Bassotta, P.; Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13, 795-808.
40. Riedl, S.; Shi, T. Molecular mechanism of caspase regulation during apoptosis. Nat Rev. Mol. Cell Biol. 2004, 5, 897-907.
41. Agostinis, P.; Buytaert, E.; Breyssens, H.; Hendrickx, N. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 2004, 3, 721-729.
42. Oleinick, N. L.; Morris, R. L.; Belichenko, I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 2002, 1, 1-21.